Dr. Rami Abboud, MD

Dr. Abboud practices at Gulf Coast Pathologists in Clearwater, Florida.

Dr. Abboud's NPI, 1285900670, was assigned on March 29, 2012. Dr. Abboud graduated from Jordan University of Science and Technology FOM in 2009. Dr. Abboud holds Florida license ME138311.

Dr. Abboud's primary practice is Gulf Coast Pathologists, at 2631 Mccormick Dr Suite 101, Clearwater, FL 33759. The practice phone is (727) 842-4848.

Dr. Abboud's primary practice is Gulf Coast Pathologists in Clearwater, Florida. Dr. Abboud is also affiliated with HCA Florida Oak Hill Hospital. The medical group on file is Access 2 Health Care Physicians. Dmand AI also links Dr. Abboud to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Abboud practices, 4 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Abboud's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Abboud is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Abboud's licenses on file in 3 states: Florida, Georgia and Michigan.

Dmand AI lists acid reflux, acute gastroduodenitis, chronic inflammatory bowel disease (IBD), cirrhosis of the liver, colonoscopy, fatty liver, gastroenteritis and gastrointestinal bleeding among the conditions Dr. Abboud treats.

CMS data shows 1,991 Medicare services from Dr. Abboud across 15 procedure codes in 2024, for 792 Medicare patients. Medicare paid $453,210 for them.

CMS counts 792 Medicare patients who saw Dr. Abboud in 2024. The largest group is 65 to 74, with 329 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 1.70, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Abboud's median patient age at 71, with 54% women.

In 2024, Dr. Abboud wrote 349 Medicare Part D claims for 181 patients. 92% of them were for generic drugs. CMS names the drug for 280 of them, across 6 drugs with 11 or more claims each, at $16,211 in total drug cost. In 2023, CMS named 423 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Abboud for performance year 2024, reported individually. Dr. Abboud accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 575 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Abboud, more than 99% of the clinicians it reports for that procedure.

Dmand AI links 2 papers to Dr. Abboud, published from 2013 to 2016. Dr. Abboud's most frequent co-authors are William J. Tremaine, MD, Moritz Binder, MD, MPH and Edward Vincent Loftus, MD.

CMS Open Payments shows 269 general payments to Dr. Abboud from 33 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $1,572.

Dr. Abboud graduated from Jordan University of Science and Technology FOM in 2009.

Dr. Abboud is in network with 17 carriers, including Excellus BlueCross BlueShield, Elevance and United Healthcare. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.